TBI News Alert Trueblue Inc (TBI) 22.50 12/25/2014 17:59:50

New Post Public Reply Private Reply Replies (0) Message Board

Dec 25, 2014 at 6:59 PM

Trueblue Inc (TBI) 22.50 $TBI

TrueBlue Shares Down 14.8% Since SmarTrend's Sell Call (TBI)
Comtex SmarTrend(R) - Wed Dec 17, 9:59AM CST
SmarTrend identified a Downtrend for TrueBlue (NYSE:TBI) on November 19th, 2014 at $23.76. In approximately 4 weeks, TrueBlue has returned 14.75% as of today's recent price of $20.25.
TBI: 22.50 (-0.28)

Employ Kelly Services For An Asymmetrical Risk/Reward
Eric Compton - Seeking Alpha - Tue Nov 18, 6:00AM CST
After falling 40% from a 52 week high of 26.17, Kelly Services ( KELYA ) represents an asymmetrical risk/reward, with likely 40% or more upside and a limited downside due to the book value present on the balance sheet with minimal debt combined with...
TBI: 22.50 (-0.28), MAN: 69.41 (+0.31), KELYA: 17.38 (+0.22)

TrueBlue Earnings Hindsight: Up 3.5% in Last 18 Days (TBI)
Comtex SmarTrend(R) - Mon Nov 10, 8:52AM CST
When TrueBlue (NYSE:TBI) reported earnings two weeks ago on October 23rd, 2014, analysts, on average, expected the company to report earnings of $0.44 on sales of $641.7 million. The company actually reported EPS of $0.54 on sales of $633.4 million, beating EPS estimates by $0.10 and missing revenue estimates by $8.3 million. Shares of TrueBlue have climbed from $24.11 to $24.96, representing a gain of 3.5% since the company reported earnings 18 days ago.
TBI: 22.50 (-0.28)

TrueBlue's (TBI) CEO Steven Cooper on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 3:40PM CDT

TBI: 22.50 (-0.28)

TrueBlue (TBI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 7:55AM CDT

TBI: 22.50 (-0.28)

TrueBlue beats by $0.09, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 7:16AM CDT

TBI: 22.50 (-0.28)

TrueBlue Reports 2014 Third Quarter Results
Business Wire - Thu Oct 23, 7:01AM CDT
TrueBlue, Inc. (NYSE:TBI) today reported results for the third quarter of 2014.
TBI: 22.50 (-0.28)

TrueBlue to Announce 2014 Third Quarter Results
Business Wire - Mon Oct 13, 3:14PM CDT
TrueBlue, Inc. (NYSE:TBI) will release 2014 third quarter results Thursday, Oct. 23, 2014.
TBI: 22.50 (-0.28)

TrueBlue's Cooper, Beharelle Named to Staffing Industry Review's "2014 Staffing 100" List of Top Industry Influencers
Business Wire - Thu Oct 09, 3:34PM CDT
TrueBlue CEO Steve Cooper and Patrick Beharelle, COO of TrueBlue Outsourcing Solutions, have both been named to the "2014 Staffing 100" by Staffing Industry Review magazine.
TBI: 22.50 (-0.28)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago TrueBlue Is Down 8.8% (TBI)
Comtex SmarTrend(R) - Mon Aug 11, 8:22AM CDT
When TrueBlue (NYSE:TBI) reported earnings 18 days ago on July 24th, 2014, analysts, on average, expected the company to report earnings of $0.31 on sales of $455.0 million. The company actually reported EPS of $0.42 on sales of $453.2 million, beating EPS estimates by $0.11 and missing revenue estimates by $1.8 million. Since the company's report, shares of TrueBlue have fallen from $29.11 to $26.54, representing a loss of 8.8% in the past 18 days.
TBI: 22.50 (-0.28)

Kelly Services Downgraded to Sell on Wide Q2 Earnings Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 4:41PM CDT
On Aug 8, Zacks Investment Research downgraded Kelly Services, Inc. (KELYA) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold).
TBI: 22.50 (-0.28), RHI: 58.91 (+0.05), MAN: 69.41 (+0.31), KELYA: 17.38 (+0.22)

Kelly Badly Misses on Q2 Earnings Despite Revenue Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 8:58AM CDT
Kelly Services, Inc. (KELYA) reported dismal second-quarter 2014 results with non-GAAP earnings of $4.0 million or 10 cents per share, down from $12.5 million or 33 cents per share in the year-ago period.
TBI: 22.50 (-0.28), RHI: 58.91 (+0.05), MAN: 69.41 (+0.31), KELYA: 17.38 (+0.22)

WEALTHMAKERS.COM Issues Bearish Research Reports on SPH, TBI, TPC, VECO, XOM
M2 - Wed Jul 30, 12:14PM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Suburban Propane Partners LP (NYSE:SPH), TRUEBLUE, INC. (NYSE:TBI), Tutor Perini Corp (NYSE:TPC), Veeco Instruments Inc (NASDAQ:VECO), EXXON MOBIL CORPORATION (NYSE:XOM)
TBI: 22.50 (-0.28), VECO: 34.60 (-0.31), SPH: 43.14 (-0.20), XOM: 93.78 (-0.81), TPC: 24.19 (-0.23)

TrueBlue Reports 2014 Second Quarter Results
Business Wire - Thu Jul 24, 7:03AM CDT
TrueBlue, Inc. (NYSE:TBI) reported results today for the second quarter of 2014.
TBI: 22.50 (-0.28)

TrueBlue to Announce 2014 Second Quarter Results
Business Wire - Wed Jul 16, 10:16PM CDT
TrueBlue, Inc. (NYSE: TBI) will release 2014 second quarter results Thursday, July 24, 2014.
TBI: 22.50 (-0.28)

TrueBlue's board elects Colleen B Brown as director
M2 - Tue Jul 08, 7:23AM CDT
TrueBlue (NYSE:TBI), a staffing, recruiting and workforce management firm, on Monday named Colleen B Brown to its board of directors.
TBI: 22.50 (-0.28)

Colleen B. Brown Joins TrueBlue Board of Directors
Business Wire - Mon Jul 07, 10:00AM CDT
TrueBlue (NYSE:TBI) announced today that Colleen B. Brown has joined the company's board of directors.
TBI: 22.50 (-0.28)

3 Big-Volume Stocks to Trade for Breakouts
at The Street - Mon Jul 07, 5:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
TBI: 22.50 (-0.28), ADHD: 4.00 (+0.24), TOUR: 12.03 (+0.30)

TrueBlue Completes Acquisition of Seaton
Business Wire - Mon Jun 30, 11:50AM CDT
TrueBlue, Inc. announced today that it has completed its previously announced acquisition of Seaton Corp., including its PeopleScout, Staff Management | SMX, HRX and StudentScout service lines.
TBI: 22.50 (-0.28)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

CURE Intl and Thoughtworks Step Into Digital Era

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Jinko Solar Joins B20 Summit: Energy Forefront Focus

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

LG Innotek Scores Hat Trick with CES Innovation Wins

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

RF MEDICAL Expands into Europe with New CE Certification

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

BD Sets Stage for Investor Day in December 2026

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Centrus Energy Welcomes Nuclear Veteran to Leadership

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...